It depends what question you want to ask. What were you thinking of
regressing against?
Steve.
On 5 Dec 2007, at 15:35, WangPing wrote:
> Dear FSL-VBM experts:
>
> Right now I only have one patient group (stroke lesions in WM), some
> lesions are mild, some are severe. I have no control group.
> I am wondering if I could use fsl-vbm in the patient group? If so
> how should I use it?
> Any suggestions are highly appreciated!
>
> Ping
>
> 比尔盖茨的电脑里刚刚安装的软件——新一
> 代的Windows Live 2.0! 立刻体验!
---------------------------------------------------------------------------
Stephen M. Smith, Professor of Biomedical Engineering
Associate Director, Oxford University FMRIB Centre
FMRIB, JR Hospital, Headington, Oxford OX3 9DU, UK
+44 (0) 1865 222726 (fax 222717)
[log in to unmask] http://www.fmrib.ox.ac.uk/~steve
---------------------------------------------------------------------------
|